Because irritable bowel syndrome is thought to be due to a disorder of brain–gut function, Dr Brian Lacy from Mayo Clinic and colleagues evaluated whether drugs acting centrally are effective in treating...
The authors of a new study aimed to investigate the prevalence of comorbid conditions among patients with irritable bowel syndrome, how they affect one another, and when they are typically diagnosed.
The authors of a new study aimed to investigate the prevalence of comorbid conditions among patients with irritable bowel syndrome, how they affect one another, and when they are typically diagnosed.
Reported prevalence rates of IBS-like symptoms in patients with quiescent ulcerative colitis vary significantly. In a new study, researchers sought to examine these rates and the effects of ongoing...
In a new study, researchers evaluated the potential association between visceral hypersensitivity and gastrointestinal symptom generation in patients with functional gastrointestinal disorders such as...
In a new study, researchers evaluated the potential association between visceral hypersensitivity and gastrointestinal symptom generation in patients with functional gastrointestinal disorders such as...
In a new study, researchers compared the outcomes associated with proactive drug monitoring and reactive drug monitoring in patients with inflammatory bowel disease receiving infliximab maintenance...
In a recent study, researchers evaluated the effects of gastrointestinal symptoms on quality of life in patients with type 2 diabetes. For details, including which gastrointestinal symptoms were assessed,...
It is not currently known whether the early use of azathioprine treatment can alter the natural history of Crohn disease. In a recent study, researchers evaluated the effects of the treatment in patients...
